Multi-family Therapy and School Refusal: an Exploratory Study With Adolescents and Their Families

NCT ID: NCT05432323

Last Updated: 2025-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

74 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-12

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether multi-family therapy is effective in the treatment of school refusal with anxiety in adolescence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anxious school refusal in adolescence is a major public health problem. The involvement of families is essential and multi-family therapy has shown its effectiveness for many mental disorders. This study aims to explore the benefit of multi-family therapy in the care of anxious school refusal in adolescence.

The method will be qualitative with phenomenological analysis of semi-structured interviews with adolescents and their parents and quantitative with a SCED design to assess the evolution of the level of anxiety of adolescents and parents, as well as personalized objectives.

The objective is therefore to improve the care of adolescents with anxious school refusal.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

School Phobia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adolescents

Multi-family therapy

Intervention Type BEHAVIORAL

8 sessions of Multi-family therapy of 3 hours each during 24 weeks

Parents

Multi-family therapy

Intervention Type BEHAVIORAL

8 sessions of Multi-family therapy of 3 hours each during 24 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multi-family therapy

8 sessions of Multi-family therapy of 3 hours each during 24 weeks

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Families with an adolescent
* Aged 12 to 18
* Totally out of school for more than 2 consecutive weeks and less than 18 months
* Follow-up at the Maison de Solenn-Maison des Adolescents (Cochin Hospital AP-HP) for a school refusal
* Having agreed to participate in a multi-family therapy
* Domiciliation in Ile de France
* Agreement of the parents and the adolescent to participate in the study: Collection of the non-opposition of non-emancipated minors and their legal representatives

Exclusion Criteria

* any family situation that makes it impossible to bring parents and children together in family therapy
* patient under curatorship or tutorship
* patient with AME (french State Medical Aid)
Minimum Eligible Age

12 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

URC-CIC Paris Descartes Necker Cochin

OTHER

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marie-Rose MORO, MD, PhD, PU-PH

Role: STUDY_DIRECTOR

Cochin Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP)

Aurélie HARF, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Cochin Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maison de Solenn Maison des Adolescents, Cochin Hospital

Paris, IDF, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A01853-38

Identifier Type: OTHER

Identifier Source: secondary_id

APHP211594

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fluoxetine for Anxious Children
NCT00000381 COMPLETED PHASE3